Cepheid Gains IVDR CE Mark for Respiratory Panel
Sunnyvale, California, United States, November 10, 2026 Cepheid, a Danaher company specializing in molecular diagnostics, has achieved CE marking...
in vitro diagnostics
Advertisement
Element Biosciences Launches CE-Marked AVITI Dx in Europe
San Diego, California — October 29, 2026 Element Biosciences, Inc. announced the commercial launch of AVITI Dx, its first...
GRAIL Galleri Wins FDA Panel Support for Cancer Test
Sunnyvale, California, September 23, 2026 GRAIL, Inc. announced that the U.S. Food and Drug Administration’s Molecular and Clinical Genetics...
Elicio Therapeutics Activates Phase 1 Study of ELI-002 7P
Boston, Aug. 10, 2026 Elicio Therapeutics, Inc. announced the activation of an investigator-initiated Phase 1 clinical study evaluating its...
Telomir Pharmaceuticals Publishes Telomir-Zn Cancer Data
Miami, August 10, 2026 Telomir Pharmaceuticals, Inc. announced the peer-reviewed publication of preclinical data showing that Telomir-Zn suppressed tumor...
Advertisements
Ibex Medical Analytics Strengthens Breast Cancer AI with CE-IVDR Approval
Boston and Tel Aviv, Israel, July 23, 2026 Ibex Medical Analytics announced it has received CE-IVDR certification for Ibex...
Bluejay Completes Patient Enrollment in SYMON-II Trial
Acton, Massachusetts, USA | July 21, 2026 Bluejay Diagnostics has announced the successful completion of patient enrollment in its...
Moderna and Oxford Launch Phase 1/2 Trial of mRNA Cancer Vaccine for Lynch Syndrome
OXFORD, UK AND CAMBRIDGE, Massachusetts – June 8, 2026 Moderna and the University of Oxford have received authorization from...
Johnson & Johnson Acquires Firefly Bio to Boost Oncology
NEW BRUNSWICK, New Jersey, USA – June 8, 2026 Johnson & Johnson has announced a definitive agreement to acquire...
Waters Secures FDA Clearance for BD BACTEC FXI System
MILFORD, Massachusetts, USA – June 3, 2026 Waters Corporation has announced U.S. Food and Drug Administration (FDA) 510(k) clearance...
Advertisement
